Why the Universal Biosensors (ASX:UBI) share price is climbing 7% today

Universal is gaining traction from its Sentia devices…
The post Why the Universal Biosensors (ASX:UBI) share price is climbing 7% today appeared first on The Motley Fool Australia. –

The Universal Biosensors, Inc. (ASX: UBI) share price is rising higher during mid-morning trade. This comes after the medical diagnostics company announced its first sales into Europe.

At the time of writing, Universal shares are up 7.32% to 66 cents.

What’s driving the Universal share price higher?

Investors appear pleased with the company’s latest update, with management hinting revenue is on track for 2021 targets.

According to this morning’s release, Universal welcomed the first sales of its Sentia device and free Sulphur Dioxide (SO2) test strips into Europe. The products were sent to companies operating in France, Italy, Germany, Spain, Portugal and Switzerland.

Universal entered into a non-exclusive agreement with Vinventions SA to market and trial Sentia in France and Italy. In addition, the company made its first sales of Sentia to AZ3Oeno SL Enologia Viva for the Spain and Portugal markets. Universal noted that both distributors are seeking a more in-depth evaluation of Sentia’s performance, before committing to new deals.

In Switzerland, Universal revealed it has completed its first sales and partnered with Swiss leading manufacturer, XC Oenologie Sarl. The distribution agreement is valid for a term of 3 years and contains minimum purchase volumes.

Management commentary

Universal Biosensors CEO, John Sharman hailed the company’s progress, saying:

The launch of Sentia into the main European markets is a significant step forward for the company. Between Vinventions, AZ3Oeno and XC Oenologie Sarl, we have access to more than 26,000 wineries across Europe.

Universal first supplied Sentia products during March 2021 and given the global COVID 19 pandemic, lockdowns and associated difficulties, sales during the first three months has been excellent. Our business is forecasting to hit $1 million of sales before the end of September. There are currently 19 distributors trialling Sentia devices across Europe. We are confident that over the next few months additional distribution agreements and sales will be made in Europe.

XC Oenologie Sarl CEO, Xavier Chevallay went on to add:

I am excited to be bringing Sentia into the Swiss market. I’m confident its speed of results and ease of use will be well received. XC Oenologie Sarl, is proud to start this collaboration with UBI and looks forward to representing Sentia with which we have carried out very convincing tests.

Over the last 12 months, the Universal share price has rocketed by more than 200%, with 2021 performance above 50%.

The post Why the Universal Biosensors (ASX:UBI) share price is climbing 7% today appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of May 24th 2021

More reading

Why the Afterpay (ASX:APT) share price is starting the week on a high
Star (ASX:SGR) share price latest to fall on anti-money laundering investigation
Up 1,600% in 12 months, why the IXUP (ASX:IXU) share price is gaining again
Why Afterpay, Altium, Hansen, & MNF shares are racing higher

Why the Japara (ASX:JHC) share price just hit a 52-week high

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!